Patient Guide: Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 29 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06855277
Status: 🟢 Enrolling Now
Condition: Prostate Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 29 locations across the country.

Top locations include:
  • • Kansas City, Kansas
  • • Myrtle Beach, South Carolina
  • • Darlinghurst, New South Wales
  • • And 26 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC - Join Clinical Trial NCTNCT06855277

How to Join This Clinical Trial - NCTNCT06855277

Learn how to participate in this PHASE3 trial studying an investigational therapy for Prostate Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Prostate Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Prostate Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06855277 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 29 locations. Find a study site near you:

Clinical Research Site

Kansas City, Kansas 66160 - United States

Status: RECRUITING

Clinical Research Site

Myrtle Beach, South Carolina 29572 - United States

Status: RECRUITING

Clinical Research Site

Darlinghurst, New South Wales 2010 - Australia

Status: RECRUITING

Clinical Research Site

Adelaide, South Australia 5000 - Australia

Status: RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510632 - China

Status: RECRUITING

Clinical Research Site

Wuhan, Hubei 430022 - China

Status: RECRUITING

Clinical Research Site

Wuhan, Hubei 430030 - China

Status: RECRUITING

Clinical Research Site

Nanjing, Jiangsu 210006 - China

Status: RECRUITING

Clinical Research Site

Nanjing, Jiangsu 210029 - China

Status: RECRUITING

Clinical Research Site

Shenyang, Liaoning 110011 - China

Status: RECRUITING

And 19 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Prostate Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships